Cole Brown’s confidence might have been a little down after his last two outings. His team’s confidence might have been just as low after its performance in the first game of last Wednesday’s ...

The South Central chapter of the Fellowship of Christian Athletes is about to make history. There has never been an FCA basketball league of any kind in West Virginia, but that will change. The South ...

A Raleigh County man is behind bars with no bond after being charged with first-degree murder in the shooting death of his ...

BECKLEY – A Raleigh County man was sentenced Wednesday for his role in a drug trafficking organization, according to a press release from the U.S. Attorney’s Office for the Southern ...

Conference Call atai and Beckley Psytech will host a conference call and live webcast today Tuesday, July 1, 2025, 2025 at 8:00 a.m. EDT.

BPL-003 is Beckley Psytech’s patent-protected, proprietary intranasal formulation of mebufotenin benzoate, administered via a nasal spray device used in a previously approved drug product.

Beckley’s mebufotenin showed a difference of 5.3 points and 6.3 points for the two therapeutic doses it tested as compared with a low-dose group used as a control when measured at Day 29 after ...

South Korean electronics giant Samsung has continued a push into the health category with an agreement to buy Xealth, a ...

BECKLEY — A U.S. District Court judge has sentenced a 25-year-old Beckley man to four months in prison for escaping from a federal facility. Kishaun Andre Jones, 25, of Beckley, was sentenced ...

Beckley Psytech’s psychedelic drug has successfully reduced the symptoms of depression in a phase 2 study, triggering the next stage of a planned merger with mental health-focused company Atai ...

Cosmo Feilding Mellen, Chief Executive Officer and Co-Founder of Beckley Psytech, said: "The achievement of our primary and secondary endpoints in this study represents an important milestone in the ...

In a Phase 2b clinical trial, Beckley’s compound, BPL-003 — an intranasal formulation of mebufotenin, a short-acting compound related to the psychedelic DMT — led to a reduction of 12.1 and ...